Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PYPD | US
0.30
6.79%
Healthcare
Biotechnology
30/06/2024
15/04/2026
4.72
4.39
4.72
4.39
PolyPid Ltd. a clinical-stage pharmaceutical company develops manufactures and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100 which helps in the prevention of sternal (bone) surgical site infections (SSIs) as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva Israel.
View LessPositive Momentum
Strength based on increasing price with high volume
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
48.5%1 month
50.0%3 months
45.9%6 months
42.6%-
-
14.58
6.89
0.56
-0.36
-
-
-21.95M
32.11M
32.11M
-
-
-
-
-496.62
1.89
0.13
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.67
Range1M
0.69
Range3M
1.11
Rel. volume
1.44
Price X volume
422.01K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| SciSparc Ltd. Ordinary Shares | SPRC | Biotechnology | 3.39 | 35.11M | 4.95% | n/a | 1.00% |
| Galecto Inc | GLTO | Biotechnology | 26.69 | 34.99M | -0.15% | n/a | 0.33% |
| NRXBF | NRXBF | Biotechnology | 0.4756 | 33.87M | n/a | 0.00% | |
| Caladrius Biosciences Inc | LSTA | Biotechnology | 4.01 | 33.36M | -11.48% | n/a | 0.58% |
| Plus Therapeutics Inc | PSTV | Biotechnology | 5.65 | 33.31M | 4.05% | n/a | -45.04% |
| Alterity Therapeutics Limited | ATHE | Biotechnology | 3.73 | 32.61M | 3.04% | n/a | 1.15% |
| Kiromic BioPharma Inc | KRBP | Biotechnology | 20.0875 | 31.05M | n/a | -258.59% | |
| Inovio Pharmaceuticals Inc | INO | Biotechnology | 1.19 | 30.90M | 7.21% | n/a | 13.42% |
| Atara Biotherapeutics Inc | ATRA | Biotechnology | 5.24 | 30.22M | 1.75% | n/a | -81.03% |
| Rafael Holdings Inc | RFL | Biotechnology | 1.22 | 30.12M | -4.69% | n/a | 2.77% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.72 | 20.90M | -6.98% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6299 | 12.17M | 1.11% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.6947 | 10.15M | -23.66% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3631 | 3.48M | 3.27% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.231 | 2.20M | 7.49% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.74 | 958.74K | -6.95% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.005 | 461.07K | 0.00% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.36 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 14.58 | 15.55 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 45.85 | - | Lower Risk |
| Debt to Equity | 6.89 | -1.23 | Expensive |
| Debt to Assets | 0.56 | 0.25 | Expensive |
| Market Cap | 32.11M | - | Emerging |